Methocarbamol Injection
Product Images NDC 36000-302

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Methocarbamol (NDC 36000-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-03.jpg (Carton 03)

NDC 36000-302-25 is a single-dose vial containing Methocarbamol Injection, which can be given through Intravenous or Intramuscular Injection. This injection is used when necessary and contains Methocarbamol, USP 100 mg; Polyethylene Glycol 300, NF 0.5 mL; and Water for Injection, USP q.s. It should be stored between 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C to 30°C. There are further instructions where the usage of the product is concerned that should be seen before usage.*

FDA Label Image

Carton-04.jpg (Carton 04)

NDC 36000-302-25 is a Methocarbamol Injection, USP with a concentration of 1,000 mg/10 mL (100 mg/mL) for intravenous or intramuscular injection. This product comes in a package of 25 single-dose vials, each containing 10 mL of solution, which should be discarded if unused. Baxter Healthcare Corporation is the manufacturer of this product and it is manufactured by Gland Pharma Limited in India. The manufacturing plot is located in the Telangana District of Hyderabad. The ML No. is TS/SGY/2019-48573. The AINXOOOOX code and the date of production are not clear from the text.*

FDA Label Image

Container-02.jpg (Container 02)

This is a product description for Methocarbamol Injection, USP, which comes in a 10 mL single-dose vial with 1,000 mg/10 mL concentration (100 mg/mL) for intravenous or intramuscular injection. It is used to relieve muscle pain and discomfort caused by Musculoskeletal conditions. Each mL of the injection contains Methocarbamol, USP (100 mg), Polyethylene Glycol 300, NF (0.5 mL), Water for Injection, USP q.s. pH adjusted with hydrochloric acid and/or sodium hydroxide. The injection should not be refrigerated after mixing with intravenous infusion fluids. The label provides detailed directions for use and storage of the product.*

FDA Label Image

Structure-01 (Structure 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.